[144] The RealReal, Inc. SEC Filing
Rhea-AI Filing Summary
The RealReal, Inc. (REAL) Form 144 notice reports a proposed sale of 151,119 common shares with an aggregate market value of $1,175,733.39, to be sold on 08/15/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The securities to be sold include 36,119 shares acquired by stock option exercise on 08/15/2025 (paid in cash) and 115,000 shares acquired by exercise on 02/01/2021 (paid in cash). The filer discloses a prior sale of 99,731 common shares on 05/21/2025 for gross proceeds of $508,820.48 by Rati Sahi Levesque. The notice includes the required representation that the seller is not aware of undisclosed material adverse information and contains the standard signature and criminal penalties warning.
Positive
- Full transaction detail provided: number of shares, acquisition dates, nature of acquisition, payment method, broker, sale date, and aggregate market value are all stated.
- Prior sale disclosed: a recent sale of 99,731 shares on 05/21/2025 with gross proceeds of $508,820.48 is included, increasing transparency.
Negative
- Filer identifiers incomplete: CIK and contact details are not present in the provided extract, limiting traceability.
- No issuer contact/address details: Issuer name, SEC file number, and issuer address fields are blank in the supplied content.
Insights
TL;DR: Routine Form 144 filing disclosing an insider sale of 151,119 REAL shares via a broker, with prior recent disposals disclosed.
The filing documents a proposed Rule 144 sale executed through Morgan Stanley Smith Barney LLC on NASDAQ and specifies acquisition dates and cash payments for the shares being sold. It also reports a prior sale of 99,731 shares on 05/21/2025 with gross proceeds recorded. The submission follows statutory disclosure requirements and includes the attestation regarding absence of undisclosed material adverse information. Filer identifiers and full contact details are not provided in the text extract.
TL;DR: Transaction details are clear: a mix of recent option exercise shares and earlier exercised shares totaling 151,119 shares proposed for sale.
The schedule shows 36,119 shares from a same-day option exercise and 115,000 from a 2021 exercise, both noted as paid in cash, which is relevant for lock-up and holding-period considerations under Rule 144. The disclosed aggregate market value and broker information provide necessary market execution context. No indications of unusual payment arrangements or non-cash consideration are present in the provided content.